Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore

MLA

Scott D. Lee, et al. “Tofacitinib as a Maintenance Therapy in Patients with Ulcerative Colitis Stratified by OCTAVE Sustain Baseline Mayo Endoscopic Subscore.” BMC Gastroenterology, vol. 23, no. 1, Feb. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12876-022-02508-2.

APA

Scott D. Lee, Jessica R. Allegretti, Flavio Steinwurz, Susan B. Connelly, Nervin Lawendy, Jerome Paulissen, & Krisztina B. Gecse. (2023). Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore. BMC Gastroenterology, 23(1), 1–12. https://doi.org/10.1186/s12876-022-02508-2

Chicago

Scott D. Lee, Jessica R. Allegretti, Flavio Steinwurz, Susan B. Connelly, Nervin Lawendy, Jerome Paulissen, and Krisztina B. Gecse. 2023. “Tofacitinib as a Maintenance Therapy in Patients with Ulcerative Colitis Stratified by OCTAVE Sustain Baseline Mayo Endoscopic Subscore.” BMC Gastroenterology 23 (1): 1–12. doi:10.1186/s12876-022-02508-2.